The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
November 2022 – Volume 29 – 6
The latest issue of the European Journal of Hospital Pharmacy (EJHP) is available. It features Systematic review of the stability of antimicrobial agents in elastomeric devices for outpatient parenteral antimicrobial therapy services based on NHS Yellow Cover Document standards, A survey of the antidote preparedness in Norwegian hospitals, Off-label use in adult palliative care – more common than expected. A retrospective chart review, Cost-saving effect of early less invasive surfactant administration versus continuous positive airway pressure therapy alone for preterm infants with respiratory distress syndrome, EAHP news: EAHP general assembly updates position paper on clinical trials and EU news: EMA/HMA joint statement on the scientific rationale supporting interchangeability of biosimilar medicines in the EU among other content.
Read the EJHP November edition HERE
Remember that you need to create an account to access to EJHP.